Literature DB >> 16685582

Doping use among tertiary education students in six developed countries.

Fotios C Papadopoulos1, Ilias Skalkidis, Jari Parkkari, Eleni Petridou.   

Abstract

Data on doping among young non-professional athletes are scarce. In order to estimate the prevalence and predictors of doping use, a standardized, anonymous questionnaire was self-administered by 2650 tertiary education students from five European Union countries (Finland, France, Germany, Greece, Italy) and Israel. The reported usage rate of a doping agent (at least once) was 2.6%, with no significant variation in the frequency of doping reporting among the participating countries. Doping was, however, less common among students of biomedical schools (OR: 0.49, 95% CI: 0.27-0.89) and was higher among males (OR: 2.16, 95% CI: 1.25-3.74). Students, who use to drink coffee or recall frequent occasions of involvement in drunkenness episodes, were more likely (twice and three times, respectively) to report doping, and students using nutritional supplements or having participated in a major athletic event were more likely (four times and twice, respectively) to report doping in comparison with students who do not. Of note is the high odds ratio for reporting individual doping when having a friend who uses doping (OR: 8.61, 95% CI: 4.49-16.53). Given the large size of the physically active young individuals in the population and the small number of professional athletes, doping in the general population may be, in absolute terms, as sizeable problem as it is among the professional athletes. There was evidence that high-risk behaviour and supplement use increased the risk of doping.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685582     DOI: 10.1007/s10654-006-0018-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  33 in total

1.  Intensive training and sports specialization in young athletes. American Academy of Pediatrics. Committee on Sports Medicine and Fitness.

Authors: 
Journal:  Pediatrics       Date:  2000-07       Impact factor: 7.124

2.  Nutritional supplements as a source for positive doping cases?

Authors:  M Kamber; N Baume; M Saugy; L Rivier
Journal:  Int J Sport Nutr Exerc Metab       Date:  2001-06       Impact factor: 4.599

Review 3.  Nutritional supplements and doping.

Authors:  Andrew Pipe; Christiane Ayotte
Journal:  Clin J Sport Med       Date:  2002-07       Impact factor: 3.638

4.  Exertional rhabdomyolysis in a body builder abusing anabolic androgenic steroids.

Authors:  N R Braseth; E J Allison; J E Gough
Journal:  Eur J Emerg Med       Date:  2001-06       Impact factor: 2.799

5.  The toxic torch of the modern Olympic Games.

Authors:  Heather M Prendergast; Todd Bannen; Timothy B Erickson; Kierre R Honore
Journal:  Vet Hum Toxicol       Date:  2003-03

Review 6.  The use of drugs in swimming.

Authors:  J C Puffer
Journal:  Clin Sports Med       Date:  1986-01       Impact factor: 2.182

7.  Emergency visits for sports-related injuries.

Authors:  C W Burt; M D Overpeck
Journal:  Ann Emerg Med       Date:  2001-03       Impact factor: 5.721

8.  Factors associated with adolescent use of doping agents: anabolic-androgenic steroids.

Authors:  A M Kindlundh; D G Isacson; L Berglund; F Nyberg
Journal:  Addiction       Date:  1999-04       Impact factor: 6.526

9.  Prevalence of anabolic steroid use by male and female adolescents.

Authors:  R Windsor; D Dumitru
Journal:  Med Sci Sports Exerc       Date:  1989-10       Impact factor: 5.411

Review 10.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more
  15 in total

Review 1.  Prevalence of doping use in elite sports: a review of numbers and methods.

Authors:  Olivier de Hon; Harm Kuipers; Maarten van Bottenburg
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

Review 2.  The use of anabolic androgenic steroids and polypharmacy: a review of the literature.

Authors:  Tonya Dodge; Margaux F Hoagland
Journal:  Drug Alcohol Depend       Date:  2011-01-12       Impact factor: 4.492

3.  Inside athletes' minds: preliminary results from a pilot study on mental representation of doping and potential implications for anti-doping.

Authors:  Andrea Petróczi; Jason Mazanov; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-05-20

4.  Potentially fatal new trend in performance enhancement: a cautionary note on nitrite.

Authors:  Andrea Petróczi; Declan P Naughton
Journal:  J Int Soc Sports Nutr       Date:  2010-06-29       Impact factor: 5.150

Review 5.  Personal and psychosocial predictors of doping use in physical activity settings: a meta-analysis.

Authors:  Nikos Ntoumanis; Johan Y Y Ng; Vassilis Barkoukis; Susan Backhouse
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

6.  The age-gender-status profile of high performing athletes in the UK taking nutritional supplements: lessons for the future.

Authors:  Andrea Petroczi; Declan P Naughton
Journal:  J Int Soc Sports Nutr       Date:  2008-01-10       Impact factor: 5.150

7.  Performance enhancement with supplements: incongruence between rationale and practice.

Authors:  Andrea Petróczi; Declan P Naughton; Jason Mazanov; Allison Holloway; Jerry Bingham
Journal:  J Int Soc Sports Nutr       Date:  2007-11-12       Impact factor: 5.150

8.  Psychological drivers in doping: the life-cycle model of performance enhancement.

Authors:  Andrea Petróczi; Eugene Aidman
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-03-10

9.  Comfort in big numbers: Does over-estimation of doping prevalence in others indicate self-involvement?

Authors:  Andrea Petróczi; Jason Mazanov; Tamás Nepusz; Susan H Backhouse; Declan P Naughton
Journal:  J Occup Med Toxicol       Date:  2008-09-05       Impact factor: 2.646

10.  Associations between physical and cognitive doping--a cross-sectional study in 2.997 triathletes.

Authors:  Pavel Dietz; Rolf Ulrich; Robert Dalaker; Heiko Striegel; Andreas G Franke; Klaus Lieb; Perikles Simon
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.